Lexeo Therapeutics, Inc.
LXEO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001907108
In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.
Superinvestors holding LXEO, Q2 2026
No superinvestor reported holding LXEO in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of LXEO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2025
0 superinvestors holding at quarter end
- Sold out
- D1 Capital Partners
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- D1 Capital Partners (−55.6%)
Q4 2024
1 superinvestor holding at quarter end
- Reduced
- D1 Capital Partners (−12.1%)
Q4 2023
1 superinvestor holding at quarter end